With help from Novartis and Sanofi, NeuroVia heads to the clinic armed with a $14M round
The corporate venture arms of Novartis and Sanofi have joined hands to back a $14 million Series A for a virtual startup called NeuroVia …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
